Please login to the form below
Symposia
This page shows the latest Symposia news and features for those working in and with pharma, biotech and healthcare.
GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing
GSK says it will now return to paying the going rate for KOLs to speak about the science behind some of its products and related disease areas in congresses, satellite symposia
Latest news
-
Changing the game in multichannel marketing
digital. Conferences, symposia and other traditional formats remain incredibly resonant for many stakeholders.”.
-
ABPI backs stroke education board game
It can be used in informal team meetings, structured study days, symposia and conferences, and does not require a specialist facilitator.
-
First biosimilar Humira launches in India
This new business will support the drug's launch with a series of medical education events and scientific symposia for healthcare professionals in India.
-
The road to smart-sourcing
From pre-launch clinical and scientific communications, key opinion leader (KOL) development and healthcare symposia, to educator programmes, market access activities and environmental market research, the value of shared intelligence and
-
WPP buys into strategic consultants RAA
Firm also runs symposia in healthcare and other sectors. WPP has take a 30 per cent stake in Richard Attias &Associates, a strategic consultancy that also organises high profile events like
More from news
Approximately 0 fully matching, plus 30 partially matching documents found.
Latest Intelligence
-
Curb your conservatism: can pharma ditch its cautious approach to creativity in comms?
COVID-19 has transformed how we approach medcomms,” said Rob Gale. “The world’s moved on from the traditional ways of exchanging information like fixed-date conferences and international symposia.
-
Follow the user – democratising medical conference design
Search and filter functions enabled physicians to locate congress materials easily, and remotely produced satellite symposia brought live congress features seamlessly into a virtual setting.
-
Change for good: the virtual congress audience is too big to be ignored
The congress elements that best transitioned to the virtual environment were oral presentations and industry symposia, whereas the least effective virtual elements included posters, networking and virtual exhibitions.
-
Congress 2020 BC (before COVID-19)
Industry increased its digital presence by creating tactics and digital shiny objects including online symposia, interactive poster sessions and webinars galore (the reach of webinars during COVID-19 increased by 51%).
-
Virtual congresses: video thrilled the cardio tsar
Doctors sat at the centre and could select the content they wanted and how they wanted to receive it: live sessions, interactive posters, webinars, meet the experts, online symposia.
More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
![[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials](//www.pmlive.com/__data/assets/image/0005/1365818/varieties/w100.png "[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials")
[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials
See how three pharma companies supported the provision of virtual and on-demand scientific meetings for HCPs during COVID-19. ( See these case studies). Lockdown propelled our industry up a steep learning curve for digital transformation, requiring
-
Out Of Office: The New Normal for Ad Agencies
International meetings and symposia have become virtual. Above all, the pandemic has provided a forced experiment in working from home, for pharma companies and agencies alike.
-
Good design saves lives
They are currently bereft of their usual congresses, symposia, company representatives and other tangible sources of reassuring information.
-
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
interact with people at the symposia or the booths.
-
A day in the life of an Associate Publications Director
I've done my fair share of training slides, newsletters, symposia and meetings, but working in publications is where I have felt the most comfortable, have had the most job satisfaction
![[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials](http://www.pmlive.com/__data/assets/image/0005/1365818/varieties/w100.png "[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials")
[CASE STUDIES] Delivering remote access to congress, symposia and enduring materials
More from PMHub
Approximately 3 fully matching, plus 24 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- First trial of a vaccine against Alzheimer’s launches
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Gilead to pay $745m for three oncology programmes from Arcus Biosciences
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Lucid Group: Orange the World
- First trial of a vaccine against Alzheimer’s launches
- New COVID variant causing concern
- PMEA 2021: A Celebration of Excellence in Patient Engagement
- From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
- Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen’s Aduhelm unlikely to get approval in Europe
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- The pandemic preparedness paradox
- First trial of a vaccine against Alzheimer’s launches
- Good NICE news for Pfizer, but Dendreon drug rejected
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
